Optimizing outcomes in anal fissure treatment: Indian expert panel consensus on combination strategies

Kushal Mital; Niranjan Agarwal

doi:10.18203/2320-6012.ijrms20254094

Authors

Kushal Mital Department of Surgery, Medicare Hospital, Thane West, Maharashtra, India
Niranjan Agarwal Department of Surgery, Salasar Nursing Home, Mira Bhayandar, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20254094

Keywords:

Anal fissure, Diltiazem, Lidocaine, Combination therapy

Abstract

Anal fissures, defined as longitudinal tears in the anoderm, are a common cause of severe anorectal pain, especially during defecation. Despite the availability of both pharmacological and surgical treatments, certain challenges persist in effectively managing chronic anal fissures (CAFs). This manuscript reviews the unmet needs in the management of anal fissures like high recurrence rates, side effects from existing treatments, improper application of topical agents and poor compliance. It also presents the recommendations from an expert panel of surgeons from all over India, aimed at addressing these issues. While standard surgical treatment, such as lateral internal sphincterotomy, is highly effective, it carries the risk of side effects, including fecal incontinence, which can significantly impact quality of life. Consequently, chemical sphincterotomy has emerged as a leading non-invasive approach, with topical agents such as diltiazem and lidocaine serving as key components in the management of anal fissures. The experts recommended the combination of diltiazem and lidocaine for its superior efficacy in promoting healing and reducing anal resting pressure, with fewer side effects than agents like nifedipine and glyceryl trinitrate. This combination offers a promising alternative for patients seeking non-surgical management of anal fissures.

Metrics

Metrics Loading ...

References

Schlichtemeier S, Engel A. Anal fissure. Aust Prescr. 2016;39(1):14-17. DOI: https://doi.org/10.18773/austprescr.2016.007

Wald A, Bharucha AE, Limketkai B, Malcolm A, Remes-Troche JM, Whitehead WE, et al. ACG clinical guidelines: Management of benign anorectal disorders. Am J Gastroenterol. 2021;116(10):1987-2008. DOI: https://doi.org/10.14309/ajg.0000000000001507

van Reijn-Baggen DA, Dekker L, Elzevier HW, Pelger RCM, Han-Geurts IJM. Management of chronic anal fissure: results of a national survey among gastrointestinal surgeons in the Netherlands. Int J Colorectal Dis. 2022;37(4):973-8. DOI: https://doi.org/10.1007/s00384-022-04115-9

Wienert V, Raulf F, Mlitz H. Anal Fissure: Symptoms, diagnosis and therapies. 1st edition. Springer. 2017. DOI: https://doi.org/10.1007/978-3-319-49244-5_1

Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of CAF: Results of a prospective, randomized, double-blind study. Dis Colon Rectum. 2002;45(11):1468-75. DOI: https://doi.org/10.1007/s10350-004-6452-1

Arroyo A, Montes E, Calderon T, Blesa I, Elia M, Salgado G, et al. Treatment algorithm for anal fissure. Consensus document of the Spanish Association of Coloproctology and the Coloproctology Division of the Spanish Association of Surgeons. Cir Esp. 2018;96(5):260-7. DOI: https://doi.org/10.1016/j.cireng.2018.05.008

Tarasconi A, Perrone G, Davies J, Coimbra R, Moore E, Azzaroli F, et al. Anorectal emergencies: WSES-AAST guidelines. World J Emerg Surg. 2021;16:48. DOI: https://doi.org/10.1186/s13017-021-00384-x

Jahnny B, Ashurst JV. Anal Fissures. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2022. Accessed October 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK526063/. Accessed on 06 October 2025.

Carapeti EA, Kamm MA, McDonald PJ, Chadwick SJ, Melville D, Phillips RK. Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate. Gut. 1999;44(5):727-30. DOI: https://doi.org/10.1136/gut.44.5.727

Altomare DF, Binda GA, Canuti S, Landolfi V, Trompetto M, Villani RD. The management of patients with primary CAF: a position paper. Tech Coloproctol. 2011;15(2):135-41. DOI: https://doi.org/10.1007/s10151-011-0683-7

Stewart Sr DB, Gaertner W, Glasgow S, Migaly J, Feingold D, Steele SR. Clinical practice guideline for the management of anal fissures. Dis Colon Rectum. 2017;60:7-14. DOI: https://doi.org/10.1097/DCR.0000000000000735

Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for CAFs. Dis Colon Rectum. 2001;44(8):1074-8. DOI: https://doi.org/10.1007/BF02234624

Talreja O, Cassagnol M. Diltiazem. In: StatPearls. Treasure Island (FL): StatPearls Publishing. 2023. Accessed October 2024. Available at: https://www.ncbi.nlm.nih.gov/books/NBK532937/. Accessed on 06 October 2025.

Kujur ADS, Paul Ekka NM, Chandra S, Lal S, Malua S. Comparative study to assess the effectiveness of topical nifedipine and diltiazem in the treatment of CAF. J Family Med Prim Care. 2020;9(11):5652-7. DOI: https://doi.org/10.4103/jfmpc.jfmpc_986_20

Mittal K, Maroo S. The effect of topical application of diltiazem or a combination of diltiazem and lidocaine in various anal conditions. Am J Pharm Tech Res. 2013;3(6).

Mital S, Pawar S, Deshpande A. Phase III, randomized, open-label study comparing fixed-dose diltiazem 2% and lidocaine 2% gel with diltiazem 2% alone in the treatment of anal fissures. Data on file. Abbott India Ltd. 2023.

Maheshwari J. Cremagel L IIS Study: Prospective, randomized, comparative study evaluating diltiazem 2% + lidocaine 2% gel vs. lidocaine 2% gel for anal fissures. Data on file. Abbott India Ltd. 2024.

Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G. Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for CAF. Br J Surg. 2007;94(2):162-7. DOI: https://doi.org/10.1002/bjs.5514

Nelson RL, Thomas K, Morgan J, Jones A. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2012;2:CD003431. DOI: https://doi.org/10.1002/14651858.CD003431.pub3

Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of CAF. Br J Surg. 2001;88(4):553-6. DOI: https://doi.org/10.1046/j.1365-2168.2001.01736.x

Fagan C, Kolber MR, Lindblad AJ. Topical treatments for anal fissure. Can Fam Physician. 2023;69(1):33. DOI: https://doi.org/10.46747/cfp.690133

Katsinelos P, Kountouras J, Paroutoglou G, Beltsis A, Chatzimavroudis G, Zavos C, et al. Aggressive treatment of acute anal fissure with 0.5% nifedipine ointment prevents its evolution to chronicity. World J Gastroenterol. 2006;12(38):6203-6. DOI: https://doi.org/10.3748/wjg.v12.i38.6203

Elssayed OE, Alsharif O, Abass MO, Mhammed AB. Chemical management of anal fissure without headache and hypotension in Almak Nimir University Hospital. Glob J Med Res. 2018;18(I3):9-14.

Patankar R, Mishra A. A prospective non-comparative study to assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in the management of constipation in patients with anal fissure/hemorrhoids/obstructive defecation syndrome. Int Surg J. 2017;4(12):3899-90. DOI: https://doi.org/10.18203/2349-2902.isj20175160